IMPORTANCE Serotonin is involved in negative affect, but whether anxiety syndromes, such as social anxiety disorder (SAD), are characterized by an overactive or underactive serotonin system has not been established. Serotonin 1A autoreceptors, which inhibit serotonin synthesis and release, are downregulated in SAD, and serotonin transporter availability might be increased; however, presynaptic serotonin activity has not been evaluated extensively.
4,5
However, only a few studies have used molecular neuroimaging to examine serotonin dysfunction in SAD directly. A single-photon emission tomography study 6 found increased serotonin transporter availability in the thalamus, but not in the raphe nuclei, in patients with SAD relative to healthy control individuals. Also, a positron emission tomography (PET) study 7 showed that SAD is associated with reduced serotonin 1A receptor binding. Somatodendritic serotonin 1A autoreceptors in the raphe nuclei, which inhibit serotonin synthesis and release, 8 and postsynaptic serotonin 1A heteroreceptors, which convey inhibitory signals in the amygdala, anterior cingulate cortex (ACC), and insula cortex, were downregulated. 7 In addition, functional neuroimaging studies of SAD 9 have demonstrated heightened, fear-induced neural reactivity in the amygdala, which is densely innervated by serotonin, 10 with alterations in the hippocampus, ACC, insula cortex, and striatum. 9, 11 Moreover, the first line of pharmacologic treatment for SAD consists of selective serotonin reuptake inhibitors (SSRIs), 12-14 which reduce excessive amygdala reactivity, restore initially suppressed ventromedial prefrontal cortex response to emotional challenge, [15] [16] [17] [18] and attenuate resting brain perfusion in the ACC and insula. 19 Thus, findings from molecular and functional neuroimaging and treatment studies indicate that serotonergic neurotransmission in the amygdala, raphe nuclei, striatum, thalamus, hippocampus, insula cortex, and ACC may be compromised in SAD. Given the inhibitory role of serotonin 1A autoreceptors on serotonin synthesis, 8 previous findings of decreased autoreceptor binding in SAD 7 may indicate increased serotonin formation and enhanced serotonergic activity. On the other hand, because blocking the serotonin reuptake with SSRIs attenuates social anxiety symptoms 12,13 and because posttreatment dietary depletion of the serotonin precursor tryptophan reverses the anxiolytic effects of SSRIs, 20 the notion that increased serotonin availability is pivotal for anxiety reduction also has support. Indeed, whether anxiety conditions such as SAD are best characterized by serotonin overactivity or underactivity remains a matter of debate.
Presynaptic serotonin activity, including synthesis and reuptake, are major contributors to serotonin neurotransmission. In vivo measurement of the serotonin synthesis rate can be accomplished by targeting the second enzymatic step of serotonin synthesis using PET and the tracer 5-hydroxytryptophan labeled with carbon 11 ([ 
21-23
The serotonin transporter, blocked by SSRI treatment, 24 is an important regulator of serotonergic neurotransmission that influences responsivity of the neural fear circuitry 25 and can be assessed successfully using PET with the tracer 11 C-labeled C]5-HTP PET. All participants gave written informed consent before the start of the study and were reimbursed for participation.
Participants were recruited through newspaper advertising. Main exclusion criteria were any other primary major psychiatric or neurologic disorder, somatic disease, ongoing or discontinued (within 2 months) psychological or psychotropic medication treatment, long-term use of prescribed medication, current drug or alcohol abuse or dependency, previous PET examination, pregnancy, or menopause. 37 Finally, a medical examination was performed. The controls underwent similar assessments. All participants were appraised as healthy, and none of the controls fulfilled criteria for any current psychiatric disorder as assessed with the Mini-International Neuropsychiatric Interview, 34 or had any lifetime history of such disorders.
Image Acquisition
The PET images were acquired using a 32-ring highresolution scanner (ECAT EXACT HR+; Siemens/CTI), which enables the acquisition of 63 contiguous planes of data with a section thickness of 2.46 mm, resulting in a total axial field of view of 155 mm. Participants fasted for 3 hours and refrained from using tobacco, alcohol, and caffeine 12 hours before the PET investigations. A venous catheter for tracer injections was inserted in the arm of the participant. For each PET investigation, participants were positioned in the scanner with their head gently fixated, and a 10-minute transmission scan was performed using 3 retractable germanium 68 rotating line sources.
[ The summation images were then normalized to the SPM8 PET template, and the transformation parameters were applied to the BP ND images. The resulting MNI-normalized [ 11 C]DASB BP ND images were subsequently smoothed with a 12-mm isotropic gaussian kernel.
C]5-HTP PET Assessments

Statistical Analysis
A priori anatomic regions of interest (ROIs) were chosen based on earlier functional, structural, and neurochemical findings in SAD and areas rich in serotonin synthesis and reuptake (eFigure in the Supplement). 6,7,9,46-50 The ROIs included the amygdala, raphe nuclei, caudate nucleus, putamen, thalamus, hippocampus, insula cortex, and ACC, defined using the Automated Anatomical Labeling library from the Wake Forest University Pickatlas 51 except for the raphe nuclei ROI, which was defined from the PVElab software. 44 We entered parametric [ 11 C]5-HTP and [ 11 C]DASB images into separate analyses in SPM8. We examined group differences between patients with SAD and controls using 2-sample t tests. To explore the relationship between severity of social anxiety symptoms and serotonin synthesis or reuptake, parametric [ ]DASB images were entered into separate regression models with the LSAS total score as the predictor. The statistical threshold for significance was set at
Supplementary Analyses
Because SAD is more prevalent in women than in men 52 and because earlier studies have found sex differences in serotonin synthesis 53 and serotonin transporter availability 54, 55 in healthy participants and patients with anxiety disorders, 31 we evaluated the effects of sex on serotonin synthesis rate and serotonin transporter availability with the interaction between sex and group (ie, SAD or control). Parametric 
Results
Serotonin Synthesis
Statistical parametric mapping within the a priori ROIs revealed an increased rate of serotonin synthesis in patients with SAD compared with controls in the amygdala, brainstem corresponding to the raphe nuclei region, caudate nucleus, putamen, hippocampus, and dorsal ACC (Figure 1 and Table) . No additional significant effect of diagnosis on [ 
Serotonin Transporter Availability
Within the predefined ROIs, increased serotonin transporter availability in patients with SAD compared with controls was found in the brainstem corresponding to the raphe nuclei region, caudate nucleus, putamen, thalamus, and insula ( Figure 3 and Table) and at a more lenient statistical threshold in the amygdala (right: MNI coordinates: 24, 2, −12; z = 2.61; cluster size, 656 mm C]DASB BP ND were found in patients with SAD compared with controls in men and women during separate analyses, without any significant interactions between sex and group for either tracer (eAppendix 2 and 3 and eTables 2-5 in the Supplement). No significant differences were observed when comparing patients with and without concurrent or previous psychiatric comorbidity or history of psychotropic medication use.
Discussion
Using PET, we found higher rates of serotonin synthesis and/or transporter availability in patients with SAD than controls in the amygdala, raphe nuclei region, caudate nucleus, putamen, thalamus, hippocampus, insula cortex, and ACC. Although this study is, to our knowledge, the first imaging study of serotonin synthesis in SAD, we replicate and extend previous single-photon emission tomography findings of increased serotonin transporter binding in the thalamus of patients with SAD.
6 These findings are consistent with an overactive presynaptic serotonin system in socially anxious individuals, which may be important for the pathogenesis of anxiety. Notably, within the SAD group, the rate of serotonin synthesis in the dorsal amygdala correlated positively with severity of social anxiety symptoms. Although the spatial resolution of PET imaging is limited, the location of the amygdala cluster is consistent with the central nucleus, 56 that is, the major output region of the amygdala, which mediates fear and anxiety. 57 Because anxious rat strains are hyperserotonergic 58, 59 and because results of imaging studies in healthy individuals indicate a positive relationship between extracellular serotonin and reactivity in the amygdala, 25,60 our [ 11 C]5-HTP results suggest that increased extracellular serotonin concentration underlies elevated anxiety and amygdala responsivity 9,47,61 in SAD. Further supporting this notion, in animals, decreased serotonin concentrations after inhibition of serotonin synthesis with parachlorophenylalanine are associated with reduced levels of anxiety, 62 whereas increased serotonin concentrations after acute SSRI 63, 64 or fenfluramine 65 administration are associated with increased anxiety. 4 Moreover, we found an increased serotonin synthesis rate in the dorsal ACC in patients with SAD relative to controls and a negative relationship between the number of serotonin reuptake sites in this region and severity of social anxiety symptoms, consistent with a proposed role for the dorsal ACC in fear expression. 66 Collectively, these findings suggest that extracellular serotonin in the amygdala and dorsal ACC is positively related to severity of social anxiety symptoms. Also, a previous study 7 reported an association between SAD and reduced levels of inhibitory serotonin 1A heteroreceptors in the amygdala and the ACC, further indicating a link between serotonin and heightened fear circuit reactivity in SAD.
9,47
Upregulated presynaptic activity observed in the present study and downregulated postsynaptic serotonin 1A receptors reported previously in SAD 7 are consistent with findings of increased serotonin transporter availability 30,31 and reduced sero- augmented reuptake may be a compensatory mechanism. The serotonin system is under strong internal feedback regulation, and alterations in synthesis, reuptake, or autoreceptor expression would lead to compensatory changes in the other components. 72 Furthermore, although serotonin synthesis and reuptake may exert differential effects on extracellular serotonin concentration, they are important contributors to serotonergic firing through replenishment of the releasable pool of serotonin in vesicles. 73 Increased synthesis rate and reuptake may consequently suggest a heightened serotonergic firing rate capacity in SAD. Moreover, we cannot exclude that our results are region specific. However, when relaxing the statistical threshold, the trend always pointed to both measures of serotonin function being enhanced in SAD, suggesting that SAD is characterized by a general overactive presynaptic serotonergic system. Among the study limitations, we could not correlate [ 
